| Literature DB >> 28540206 |
Abstract
AIM: To report our experience of acute kidney injury (AKI) developed after exposure to poisonous substance.Entities:
Keywords: Acute kidney injury; Methanol; Organophosphorus compounds; Paraphenylene diamine; Paraquat; Poisons
Year: 2017 PMID: 28540206 PMCID: PMC5424438 DOI: 10.5527/wjn.v6.i3.162
Source DB: PubMed Journal: World J Nephrol ISSN: 2220-6124
Contribution from different substances (n = 184)
| PPD | 135 | 73.36 |
| Methanol | 8 | 4.34 |
| CuSO4 | 5 | 2.71 |
| OP | 5 | 2.71 |
| Paraquat | 5 | 2.71 |
| Tartric acid | 4 | 2.17 |
| Phenobarbitone | 3 | 1.63 |
| Benzodiazipines | 2 | 1.08 |
| Datura | 2 | 1.08 |
| Ammonium dichromate | 1 | 0.54 |
| Rat killer | 1 | 0.54 |
| Fish gallbladder | 1 | 0.54 |
| Acetic acid | 1 | 0.54 |
| Arsenic | 1 | 0.54 |
| Boiler water | 1 | 0.54 |
| Multiple substances taken in combination | 9 | 4.89 |
PPD: Paraphenylene diamine; OP: Organo phosphorus.
Presenting symptoms (n = 184)
| Oligoanuria | 93 | All groups except phenobarbitone |
| Vomiting | 90 | All groups |
| Hematuria/cola color urine | 86 | PPD, CuSO4, Paraquat |
| Massive facial/neck swelling ± difficulty in swallowing | 74 | PPD |
| Hemetamesis | 16 | CuSO4, OP, Paraquat, boiler water |
| Altered level of consciousness | 16 | Methanol, pnenobarbirones, benzodiazepines, OP |
| Temporary loss of vision | 2.17 | Methanol |
PPD: Paraphenylene diamine; OP: Organo phosphorus.
Laboratory and other parameters on presentation in different groups (median values and ranges given)
| DOI | 4 (1-28) | 5 (1-15) | 4 (2-5) | 5 (2-6) | 3 (1-5) | 5 (1-25) |
| Hb, g/dL | 11.95 (2.5-21.5) | 13.7 (9-19.5) | 5.5 (2-9.9) | 10.3 (6.7-13.4) | 8 (6.3-11) | 11.5 (7.6-15.6) |
| Plt, × 109/L | 234 (59-603) | 285.5 (58-610) | 303 (101-687) | 114 (98-121) | 90 (47-213) | 211.5 (10-910) |
| Urea, mg/dL | 183 (69-496) | 123.5 (47-329) | 282 (108-384) | 234 (114-367) | 224 (197-338) | 213.5 (65-483) |
| Creat, mg/dL | 7.81 (3-25.15) | 5.25 (2-13.79) | 10.3 (7.1-10.8) | 9 (3.9-14.71) | 9.9 (4.7-13.4) | 10.25 (2.9-24.49) |
| K, meq/L | 5.8 (2-9.3) | 5.85 (2.7-7.9) | 5.4 (3.4-6.8) | 5.9 (3.7-6.9) | 6 (5.5-6.8) | 4.4 (1.9-6.9) |
| LDH, U/L | 4785 (236-29130) | 486 (95-4000) | 11223 (974-13245) | 2349 (891-3448) | 1429 (756-6432) | 1169 (179-4635) |
| CK, U/L | 115989 (54-1998000) | 115220 (387-228300) | Available for one patient only | 699 (126-1012) | NA | 806 (32-98720) |
| AST, U/L | 2024 (15-17380) | 136 (46-1748) | 48 (34-425) | 167 (78-557) | 209 (88-456) | 70.5 (3-771) |
| ALT, U/L | 975 (13-6310) | 104 (59-766) | 34 (23-150) | 112 (34-316) | 101 (72-338) | 36 (10-1036) |
| HD (ses rq) | 4 (1-13) | 1.5 (1-6) | 3 (1-12) | 2 (1-3) | 2 (1-5) | 2 (1-10) |
| HD done in | 131/135 | 8/8 | 5/5 | 4/5 (one died before starting HD) | 5/5 | 23/26 |
DOI: Days of insult; Hb: Hemoglobin; plt: Platelet; K: Potassium; LDH: Lactate dehydrogenase; CK: Creatinine phosphokinase; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; HD: Hemodialysis; ses rq: Sessions required; PPD: Paraphenylene diamine; OP: Organo phosphorus.
Outcome in different groups (n = 184)
| Complete recovery | 108 | 5 | 3 | 2 | 1 | 14 |
| Partial recovery and lost follow-up | 6 | 1 | 0 | 0 | 0 | 4 |
| Left against advice during acute phase | 2 | 0 | 0 | 0 | 0 | 1 |
| Died | 19 | 2 | 2 | 3 | 4 | 7 |
PPD: Paraphenylene diamine; OP: Organo phosphorus.